Precision medicine approach to discover the effective therapy for Hydroxychloroquine No respondents in COVID-19
Keerthi G S Nair, Anuraj J, Athira S, P Manoj Kumar
The world is gearing up to battle against the Coronavirus disease 19 (COVID-19) outbreak which has already led to more than 323,256 deaths and 4,893,186 confirmed cases globally as on May 22, 2020 [1]. There are currently no drugs licensed for the treatment or prevention of COVID-19. While several drug trials are ongoing, advisories were published on the use of hydroxychloroquine as prophylaxis for SARS-CoV-2 infection [2-4]. The existence of hydroxychloroquine failure was even recorded in many cases [5] and that is to be suggested for the resistance developed.
Article Details
Unique Paper ID: 155020

Publication Volume & Issue: Volume 8, Issue 12

Page(s): 1228 - 1229
Article Preview & Download

Share This Article

Join our RMS

Conference Alert

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024

Last Date: 15th March 2024

Call For Paper

Volume 10 Issue 10

Last Date for paper submitting for March Issue is 25 June 2024

About Us enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on

Social Media

Google Verified Reviews